MYO1G

Unconventional myosin-Ig · B0I1T2 · MYO1G on Sugi Atlas →

2,007 patent compounds predicted against MYO1G, 1,764 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Molibresib Molibresib (SCHEMBL1872390) 1.00 1/20
Molibresib Molibresib (SCHEMBL12671490) 1.00 1/20
Molibresib Molibresib (SCHEMBL12966358) 1.00 1/20
SCHEMBL9998851 SCHEMBL9998851 0.91 1/20
SCHEMBL14756282 SCHEMBL14756282 0.88 1/20
SCHEMBL12966165 SCHEMBL12966165 0.87 1/20
SCHEMBL14756215 SCHEMBL14756215 0.87 1/20
SCHEMBL14756339 SCHEMBL14756339 0.87 1/20
SCHEMBL9998825 SCHEMBL9998825 0.86 1/20
SCHEMBL1874116 SCHEMBL1874116 0.85 1/20
SCHEMBL12671221 SCHEMBL12671221 0.85 1/20
SCHEMBL14756021 SCHEMBL14756021 0.85 1/20
SCHEMBL14756240 SCHEMBL14756240 0.85 1/20
SCHEMBL14756287 SCHEMBL14756287 0.85 1/20
SCHEMBL14756335 SCHEMBL14756335 0.85 1/20
SCHEMBL14756409 SCHEMBL14756409 0.85 1/20
SCHEMBL15969460 SCHEMBL15969460 0.85 1/20
SCHEMBL15969471 SCHEMBL15969471 0.85 1/20
SCHEMBL14756206 SCHEMBL14756206 0.84 1/20
SCHEMBL14756217 SCHEMBL14756217 0.84 1/20

Clinical trials — most relevant to MYO1G by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure PHASE2COMPLETED
Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM) PHASE2COMPLETED
Transcutaneous Functional Magnetic Muscle Stimulation in Critically Ill nanUNKNOWN
Genetic Testing in Primary Congenital Glaucoma Patients nanUNKNOWN
Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia nanCOMPLETED
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China nanENROLLING_BY_INVITATION
CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation nanRECRUITING
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure nanRECRUITING
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Clinical and Genetic Studies in Families With Myopia and Related Diseases nanCOMPLETED
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development nanCOMPLETED
Characteristics of Nondystrophic Myotonias nanCOMPLETED
Family Myopia Study nanCOMPLETED
Contractile Cross Sectional Areas and Muscle Strength in Patients With Congenital Myopathies nanCOMPLETED
Phenotype - Genotype Correlation in a Sample of Egyptian Patients With Congenital Myopathies and Congenital Muscular Dystrophies nanRECRUITING
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
A Single Center Prospective Study in an Estimated 570 Patients Who Underwent Genetic Screening at UZ Brussel in the Context of a Primary Cardiac Arrhythmia. Patients Showing a Variant Class 3,4 or 5 in SCN4A or CLCN1 Will Undergo a Clinical and Electrophysiological Review After IC. nanNOT_YET_RECRUITING
Congenital Muscle Disease Study of Patient and Family Reported Medical Information nanRECRUITING
Genetic Analysis of African-Americans With High Blood Pressure nanCOMPLETED
Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium nanCOMPLETED
Clinical and Functional Assessment of Patients With Inherited Non-Duchenne Myopathies in Sohag University Hospital nanRECRUITING
Characteristics of Idiopathic Familial Voice Disorders nanCOMPLETED
Whole-exome Sequencing in Childhood Obesity nanCOMPLETED
The Role of Muscle Protein Breakdown in the Regulation of Muscle Quality in Frail Elderly Individuals nanCOMPLETED
Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease nanCOMPLETED
The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study nanUNKNOWN
Molecular and Genetic Studies of Congenital Myopathies nanRECRUITING
GARM II: A Study on the Genetics of Age-related Maculopathy nanACTIVE_NOT_RECRUITING
Genomewide Screening of Pathological Myopia nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a MYO1G binder may also engage these)

ProteinNameSimilarity
Q5SUA5 1.000 Q5SUA5 →
Q5ZMC2 0.996 Q5ZMC2 →
Q8N1T3 0.990 Q8N1T3 →
Q9HD67 0.987 Q9HD67 →
D3ZJP6 0.986 D3ZJP6 →
Q13402 0.985 Q13402 →
Q29P71 0.984 Q29P71 →
A5PF48 0.984 A5PF48 →
A2AQP0 0.984 A2AQP0 →
F8VQB6 0.983 F8VQB6 →
Q23979 0.983 Q23979 →
Q6GPA1 0.982 Q6GPA1 →
Q03479 0.982 Q03479 →
O94832 0.981 O94832 →
Q9V3Z6 0.981 Q9V3Z6 →
Q9WTI7 0.981 Q9WTI7 →
Q6PIF6 0.981 Q6PIF6 →
E7F9L8 0.981 E7F9L8 →
A7E2Y1 0.981 A7E2Y1 →
Q23978 0.981 Q23978 →
Q5SYD0 0.981 Q5SYD0 →
O00934 0.981 O00934 →
Q27966 0.981 Q27966 →
F1PRN2 0.980 F1PRN2 →
Q6ZSI9 0.980 Q6ZSI9 →
P79114 0.980 P79114 →
Q5R607 0.979 Q5R607 →
DHX30 ATP-dependent RNA helicase DHX30 0.978 landscape →
Q99MZ6 0.978 Q99MZ6 →
Q767K6 0.978 Q767K6 →